Literature DB >> 16954606

Dopamine-1 receptor agonist, but not cocaine, modulates sigma(1) gene expression in SVG cells.

Oren Ben-Ami1, Noa Kinor, Alexander Perelman, Gal Yadid.   

Abstract

It has been hypothesized that sigma(1) receptors (sigma(1)Rs) are involved in the effects of cocaine abuse. Many in vitro and in vivo studies have already indicated an influence of sigma(1)R ligands on dopaminergic transmission; however, the direct effect on the brain is poorly understood. Herein we describe the effects of cocaine and the selective dopamine-1 receptor (D(1)R) agonist, (+)-SKF38393, on gene expression of the sigma(1)R in a human fetal astrocyte cell line (SVG cells). This study provides the first evidence for the expression of sigma(1)RmRNAin these cells. Our results show that treatment of SVG cells with various cocaine concentrations for several time durations showed no significant alterations in sigma(1)R gene expression, as detected by real-time quantitative RT-PCR, whereas treating cells for 24 h with (+)-SKF38393 caused a significant down-regulation in sigma(1) transcripts. This (+)-SKF38393-induced effect was blocked by the D(1)R selective antagonist (+)-SCH23390. These results suggest that the effect of cocaine on sigma(1) gene expression in the brain might be indirect and mediated through D(1)R.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954606     DOI: 10.1385/jmn:29:2:169

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   2.866


  39 in total

1.  Primer3 on the WWW for general users and for biologist programmers.

Authors:  S Rozen; H Skaletsky
Journal:  Methods Mol Biol       Date:  2000

2.  Addiction to cocaine and amphetamine.

Authors:  S E Hyman
Journal:  Neuron       Date:  1996-05       Impact factor: 17.173

3.  Cocaine binding at sigma receptors.

Authors:  J Sharkey; K A Glen; S Wolfe; M J Kuhar
Journal:  Eur J Pharmacol       Date:  1988-04-27       Impact factor: 4.432

4.  Cocaine affects the dynamics of cytoskeletal proteins via sigma(1) receptors.

Authors:  T P Su; T Hayashi
Journal:  Trends Pharmacol Sci       Date:  2001-09       Impact factor: 14.819

5.  Dopamine increases glial cell line-derived neurotrophic factor in human fetal astrocytes.

Authors:  N Kinor; R Geffen; E Golomb; T Zinman; G Yadid
Journal:  Glia       Date:  2001-02       Impact factor: 7.452

6.  Involvement of the sigma1 receptor in the cocaine-induced conditioned place preference.

Authors:  P Romieu; R Martin-Fardon; T Maurice
Journal:  Neuroreport       Date:  2000-09-11       Impact factor: 1.837

7.  Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides.

Authors:  Rae R Matsumoto; Kari A McCracken; Buddy Pouw; Ying Zhang; Wayne D Bowen
Journal:  Neuropharmacology       Date:  2002-06       Impact factor: 5.250

8.  Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742A.

Authors:  M Poncelet; V Santucci; R Paul; C Gueudet; S Lavastre; J Guitard; R Steinberg; J P Terranova; J C Brelière; P Soubrié
Journal:  Neuropharmacology       Date:  1993-06       Impact factor: 5.250

9.  sigma Receptor antagonists block the development of sensitization to cocaine.

Authors:  H Ujike; S Kuroda; S Otsuki
Journal:  Eur J Pharmacol       Date:  1996-01-25       Impact factor: 4.432

10.  Selection of appropriate control genes to assess expression of tumor antigens using real-time RT-PCR.

Authors:  Joeri L Aerts; Monica I Gonzales; Suzanne L Topalian
Journal:  Biotechniques       Date:  2004-01       Impact factor: 1.993

View more
  2 in total

Review 1.  Glial modulators as potential treatments of psychostimulant abuse.

Authors:  Patrick M Beardsley; Kurt F Hauser
Journal:  Adv Pharmacol       Date:  2014

2.  A Role for Sigma Receptors in Stimulant Self Administration and Addiction.

Authors:  Jonathan L Katz; Tsung-Ping Su; Takato Hiranita; Teruo Hayashi; Gianluigi Tanda; Theresa Kopajtic; Shang-Yi Tsai
Journal:  Pharmaceuticals (Basel)       Date:  2011
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.